BioPlex™ 2200 multiplexed system: Simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus

References

• Namjou B, Kilpatrick J, Harley JB. Genetics of clinical expression in SLE. Autoimmunity 2007; 40: 602–612
   PubMed Web of Science ®Google Scholar
• Nossent J, Cikes N, Kiss E, Marchesoni A, Nassonova V, Mosca M, Olesinska M, Pokorny G, Rozman B, Schneider M, Vlachoyiannopoulos PG, Swaak A. Current causes of death in systemic lupus erythematosus in Europe, 2000–2004: Relation to disease activity and damage accrual. Lupus 2007; 16: 309–317
   PubMed Web of Science ®Google Scholar
• Bevra H. Antibodies to DNA. New Engl J Med 1998; 338: 1359–1368
   PubMedGoogle Scholar
• Riboldi P, Gerosa M, Moroni G, Radice A, Allegri F, Sinico A, Tincani A, Meroni PL. Anti-DNA antibodies: A diagnostic and prognostic tool for systemic lupus erythematosus?. Autoimmunity 2005; 38: 39–45
   PubMed Web of Science ®Google Scholar
• Düzgün N, Sahin M, Genç Y, Tutkak H. Antinucleosome antibodies and systemic lupus erythematosus. Ann N Y Acad Sci 2007; 1109: 421–428
   PubMed Web of Science ®Google Scholar
• Půtová I, Dostal C, Becvar R. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases. Ann N Y Acad Sci 2007; 1109: 275–286
   PubMedGoogle Scholar
• Stinton LM, Barr SG, Tibbles LA, Yilmaz S, Sar A, Benedikttson H, Fritzler MJ. Autoantibodies in lupus nephritis patients requiring renal transplantation. Lupus 2007; 16: 394–400
   PubMed Web of Science ®Google Scholar
• López-Hoyos M, Cabeza R, Martínez-Taboada VM, Crespo J, SanSegundo D, Blanco R, López-Escribano H, Peña M, Rodríguez-Valverde V. Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunofluorescence assay in patients with systemic lupus erythematosus. Lupus 2005; 14: 505–509
   PubMedGoogle Scholar
• Mortensen ES, Fenton KA, Rekvig OP. Lupus nephritis: The central role of nucleosomes revealed. Am J Pathol 2008; 172: 275–283
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard G, Gilburd B, Shovman O, Blank M, Berdichevski S, Langevitz P, Shoenfeld Y. The homogeneous multiplexed system – A new method for autoantibody profile in systemic lupus erythematosus. Clin Dev Immunol 2005; 12: 107–111
   PubMedGoogle Scholar
• Desplat-Jego S, Bardin N, Larida B, Sanmarco M. Evaluation of the BioPlex™ 2200 ANA screen for the detection of antinuclearantibodies and comparison with conventional methods. Ann N Y Acad Sci 2007; 1109: 245–255
   PubMedGoogle Scholar
• Shovman O, Gilburd B, Barzilai O, Shinar E, Larida B, Zandman-Goddard G, Binder SR, Shoenfeld Y. Evaluation of the BioPlex™ 2200 ANA screen: Analysis of 510 healthy subjects: Incidence of natural/predictive autoantibodies. Ann N Y Acad Sci 2005; 1050: 380–388
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M. International Society of Nephrology Working Group on the classification of lupus nephritis; Renal Pathology Society Working Group on the classification of lupus nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521–530
   PubMed Web of Science ®Google Scholar
• Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 37–46
   Web of Science ®Google Scholar
• Tozzoli R. Recent advances in diagnostic technologies and their impact in autoimmune diseases. Autoimmun Rev 2007; 6: 334–340
   PubMed Web of Science ®Google Scholar
• Mahler M, Fritzler MJ. Anti-dsDNA antibody testing in the clinic: Farr or ELISA?. Nat Clin Pract Rheumatol 2007; 3: 72–73
   PubMedGoogle Scholar
• Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A. Fifty years of anti-ds DNA antibodies: Are we approaching journey's end?. Rheumatology (Oxford) 2007; 46: 1052–1056
   PubMed Web of Science ®Google Scholar
• Haddouk S, Ben Ayed M, Baklouti S, Hachicha J, Bahloul Z, Masmoudi H. Clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus patients. Clin Rheumatol 2005; 24: 219–222
   PubMedGoogle Scholar
• Düzgün N, Sahin M, Genç Y, Tutkak H. Antinucleosome antibodies and systemic lupus erythematosus. Ann N Y Acad Sci 2007; 1109: 421–428
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Adrianzén OA, Koutouzov S, Mota RM, das Chagas Medeiros MM, Bach JF, de Holanda Campos H. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: A prospective study comparing anti-nucleosome with anti-dsDNA antibodies. J Rheumatol 2006; 33: 1538–1544
   PubMedGoogle Scholar
• Ramos-Casals M, Campoamor MT, Chamorro A, Salvador G, Segura S, Botero JC, Yagüe J, Cervera R, Ingelmo M, Font J. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: Prevalence and clinical significance in 667 patients. Lupus 2004; 13: 777–783
   PubMedGoogle Scholar
• Saisoong S, Eiam-Ong S, Hanvivatvong O. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients. Clin Exp Rheumatol 2006; 24: 51–58
   PubMedGoogle Scholar